Does immunotherapy protect equines from reinfection by the oomycete Pythium insidiosum?

Clin Vaccine Immunol. 2011 Aug;18(8):1397-9. doi: 10.1128/CVI.05150-11. Epub 2011 Jun 29.

Abstract

A cutaneous Pythium insidiosum reinfection was diagnosed in an equine in Brazil. Lesions with focal presentation appeared 2 years apart. The first infection and even immunotherapy were not likely to develop enough immune response to prevent reinfection. The use of adjuvants should be considered in the immunotherapy of pythiosis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Animals
  • Brazil
  • Dermatomycoses / immunology
  • Dermatomycoses / prevention & control
  • Dermatomycoses / therapy
  • Dermatomycoses / veterinary*
  • Histocytochemistry
  • Horse Diseases / immunology*
  • Horse Diseases / prevention & control
  • Horse Diseases / therapy*
  • Horses
  • Immunotherapy / methods*
  • Microscopy
  • Mycology
  • Pythiosis / immunology
  • Pythiosis / prevention & control
  • Pythiosis / therapy
  • Pythiosis / veterinary*
  • Pythium / immunology*
  • Secondary Prevention
  • Skin / pathology

Substances

  • Adjuvants, Immunologic